441 related articles for article (PubMed ID: 8792950)
1. Angiotensin II receptor antagonists: the prototype losartan.
Schaefer KL; Porter JA
Ann Pharmacother; 1996 Jun; 30(6):625-36. PubMed ID: 8792950
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor antagonism: losartan - sites and mechanisms of action.
Triggle DJ
Clin Ther; 1995; 17(6):1005-30. PubMed ID: 8750395
[TBL] [Abstract][Full Text] [Related]
3. Losartan potassium: a review of its pharmacology, clinical efficacy and tolerability in the management of hypertension.
Goa KL; Wagstaff AJ
Drugs; 1996 May; 51(5):820-45. PubMed ID: 8861549
[TBL] [Abstract][Full Text] [Related]
4. [Angiotensin-II receptor blockers].
Metelitsa VI
Ter Arkh; 1996; 68(8):64-7. PubMed ID: 9019837
[No Abstract] [Full Text] [Related]
5. Angiotensin II antagonists: a new class of antihypertensive agent.
Waeber B; Brunner HR
Br J Clin Pract; 1996; 50(5):265-8. PubMed ID: 8794603
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor inhibition. A new therapeutic principle.
Messerli FH; Weber MA; Brunner HR
Arch Intern Med; 1996 Sep; 156(17):1957-65. PubMed ID: 8823149
[TBL] [Abstract][Full Text] [Related]
7. A risk-benefit assessment of losartan potassium in the treatment of hypertension.
Burrell LM
Drug Saf; 1997 Jan; 16(1):56-65. PubMed ID: 9010643
[TBL] [Abstract][Full Text] [Related]
8. Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension.
Goldberg AI; Dunlay MC; Sweet CS
Am J Cardiol; 1995 Apr; 75(12):793-5. PubMed ID: 7717281
[TBL] [Abstract][Full Text] [Related]
9. A new class of antihypertensive therapy: angiotensin II receptor antagonists.
Ellis ML; Patterson JH
Pharmacotherapy; 1996; 16(5):849-60. PubMed ID: 8888079
[TBL] [Abstract][Full Text] [Related]
10. Association between cough and angiotensin converting enzyme inhibitors versus angiotensin II antagonists: the design of a prospective, controlled study.
Lacourcière Y; Lefebvre J; Nakhle G; Faison EP; Snavely DB; Nelson EB
J Hypertens Suppl; 1994 Jul; 12(2):S49-53. PubMed ID: 7965266
[TBL] [Abstract][Full Text] [Related]
11. New competition in the realm of renin-angiotensin axis inhibition; the angiotensin II receptor antagonists in congestive heart failure.
Martineau P; Goulet J
Ann Pharmacother; 2001 Jan; 35(1):71-84. PubMed ID: 11197588
[TBL] [Abstract][Full Text] [Related]
12. New therapeutic agents in the management of hypertension: angiotensin II-receptor antagonists and renin inhibitors.
Foote EF; Halstenson CE
Ann Pharmacother; 1993 Dec; 27(12):1495-503. PubMed ID: 8305785
[TBL] [Abstract][Full Text] [Related]
13. Candesartan cilexetil: an angiotensin II receptor blocker.
Stoukides CA; McVoy HJ; Kaul AF
Ann Pharmacother; 1999 Dec; 33(12):1287-98. PubMed ID: 10630830
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II receptors and angiotensin II receptor antagonists.
Timmermans PB; Wong PC; Chiu AT; Herblin WF; Benfield P; Carini DJ; Lee RJ; Wexler RR; Saye JA; Smith RD
Pharmacol Rev; 1993 Jun; 45(2):205-51. PubMed ID: 8372104
[No Abstract] [Full Text] [Related]
15. Angiotensin II receptor antagonists in heart failure: rationale and design of the evaluation of losartan in the elderly (ELITE) trial.
Pitt B; Chang P; Timmermans PB
Cardiovasc Drugs Ther; 1995 Oct; 9(5):693-700. PubMed ID: 8573552
[TBL] [Abstract][Full Text] [Related]
16. The future role of losartan.
Hansson L
J Hum Hypertens; 1995 Nov; 9 Suppl 5():S55-8. PubMed ID: 8583483
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin receptor antagonists.
Wong W; Howes L
Aust Fam Physician; 2000 Jul; 29(7):653-5, 658. PubMed ID: 10914449
[TBL] [Abstract][Full Text] [Related]
18. Losartan for hypertension.
Med Lett Drugs Ther; 1995 Jun; 37(951):57-8. PubMed ID: 7783693
[No Abstract] [Full Text] [Related]
19. Olmesartan medoxomil: the seventh angiotensin receptor antagonist.
Gardner SF; Franks AM
Ann Pharmacother; 2003 Jan; 37(1):99-105. PubMed ID: 12503943
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
